SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001549595-23-000048
Filing Date
2023-10-12
Accepted
2023-10-12 16:06:47
Documents
67
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrix-20230831.htm   iXBRL 10-Q 1460288
2 EX-10.1 nrix-20230831xex101.htm EX-10.1 37799
3 EX-10.2 nrix-20230831xex102.htm EX-10.2 30615
4 EX-10.3 nrix-20230831xex103.htm EX-10.3 1124572
5 EX-31.1 nrix-20230831xex311.htm EX-31.1 10851
6 EX-31.2 nrix-20230831xex312.htm EX-31.2 10841
7 EX-32.1 nrix-20230831xex321.htm EX-32.1 8424
  Complete submission text file 0001549595-23-000048.txt   6595865

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrix-20230831.xsd EX-101.SCH 41338
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nrix-20230831_cal.xml EX-101.CAL 46575
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nrix-20230831_def.xml EX-101.DEF 201827
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrix-20230831_lab.xml EX-101.LAB 518783
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrix-20230831_pre.xml EX-101.PRE 330975
61 EXTRACTED XBRL INSTANCE DOCUMENT nrix-20230831_htm.xml XML 302175
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-39398 | Film No.: 231322795
SIC: 2834 Pharmaceutical Preparations